Core A: Administrative Core
Core A: Administrative Core
批准号:
10203851
负责人:
Roy S Herbst
金额:
$15.48万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
未结题
起止时间:
2015-08-26 至 2025-07-31
关键词:
AchievementAdvocacyAdvocateBasic ScienceCancer BiologyClinicalClinical ResearchCollaborationsCommunicationConflict (Psychology)ConsultationsDataDevelopmentDisputesEnsureEvaluationFoundationsFundingFutureGoalsGovernmentGrantHuman ResourcesHuman Subject ResearchInfrastructureInstitutionLaboratory FindingLeadershipMalignant neoplasm of lungMonitorNational Cancer InstituteOccupational activity of managing financesPatientsPhilanthropic FundPreparationPrincipal InvestigatorPrivatizationProgram EvaluationProgress ReportsPublicationsRegulationResearchResearch PersonnelResearch PriorityResourcesSeriesSourceTimeTimeLineTranslational ResearchTranslationsUnited States National Institutes of HealthUniversitiesYale Cancer Centeranticancer researchcareercost effectivemeetingsneoplasm resourcenoveloperationoutreachpersonalized medicineprogramssuccesssymposiumtranslational cancer researchwebsite development
中文摘要
核心摘要
管理核心(核心A)由耶鲁大学肺部孢子的首席研究员罗伊·赫布斯特(Roy Herbst)指导
癌症(YSILC),并共同导演的艾德卡夫坦,与支持的计划财务管理团队。
行政核心的仔细监督对于确保耶鲁大学在龙的SPORE的成功至关重要
癌核心A是YCC研究管理局提供的现有基础设施的扩展,
并促进跨学科的研究工作。行政核心作为中央协调机构
所有YSILC调查员的一个点,负责监控所有项目和核心的进展,
转化/临床终点。核心总监和联席总监沿着YISLC联席主要研究者(陈博士)
负责领导YSILC计划,确定转化研究的优先事项,确定新的
从新兴的数据转化研究的机会,监测所有项目的进展,核心和
发展项目和确定项目方向的变化,核心和转化研究,
needed.核心A促进了YSILC研究者之间的互动,以加快
将实验室结果纳入拟议和未来的临床研究。如果需要,核心A主管将管理
YSILC调查员之间的冲突。作为一个团队,核心人员监控财务,
项目和核心领导人之间的沟通,并协调会议,包括每周肺癌
翻译小组研讨会系列,执行委员会每月会议,
内部/外部咨询委员会和年度YSILC SEP和DRP研讨会。除了这些
核心是与NCI、其他肺癌SPORE、耶鲁癌症中心和
耶鲁大学,并协调外联工作,包括出版物(内部和外部)、网站
发展,研讨会,患者/研究宣传活动和筹款计划。通过这些
行政活动,核心A是必不可少的组织YSILC计划,制定一个
耶鲁大学肺癌基础/临床/转化研究的广泛文化,
声明的计划目标,最终目标是对肺部疾病患者产生重大临床影响,
癌
英文摘要
CORE SUMMARY
The Administrative Core (Core A) is directed by Roy Herbst, Principal Investigator of the Yale SPORE in Lung
Cancer (YSILC), and co-directed by Ed Kaftan, with support from the program financial management team.
Careful oversight by the Administrative Core will be critical to ensure the success of the Yale SPORE in Lung
Cancer. Core A is an extension of existing infrastructure provided by YCC Research Administration to support
and facilitate transdisciplinary research efforts. The Administrative Core serves as the central coordination
point for all YSILC investigators, with responsibility for monitoring the progress of all projects and cores toward
a translational/clinical endpoint. The Core Director and Co-Director along with the YISLC Co-PI (Dr. Chen)
have responsibility for leading the YSILC program, setting translational research priorities, identifying new
translational research opportunities from emerging data, monitoring the progress of all projects, cores and
developmental projects and determining changes in direction of projects, cores and translational research as
needed. Interactions among YSILC investigators is facilitated by Core A to accelerate the translation of
laboratory findings into the proposed and future clinical studies. If required, the Core A Director will manage
conflicts among YSILC investigators. As a team, the Core personnel monitors finances, maintains
communications among project and core leaders and coordinates meetings, including the weekly lung cancer
translational group seminar series, monthly meetings of the Executive Committee, annual meetings of the
Internal/External Advisory boards and the annual YSILC SEP and DRP Symposium. In addition to these
functions, the Core is the primary interface with the NCI, other lung cancer SPOREs, Yale Cancer Center and
Yale University, and coordinates outreach efforts, including publications (internal and external), website
development, seminars, patient/research advocacy activities, and fundraising programs. Through these
administrative activities, Core A is essential to the organization of the YSILC program, to developing a
widespread culture of lung cancer basic/clinical/translational research at Yale and to the efficient achievement
of the stated program objectives, with the ultimate goal of a significant clinical impact for patients with lung
cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Yale Cancer Center NCTN LAPS
-
批准号:10359158
-
项目类别:
-
资助金额:$48.49万
-
财政年份:2019
-
负责人:Roy S Herbst
-
依托单位:
Yale Cancer Center NCTN LAPS
-
批准号:10582614
-
项目类别:
-
资助金额:$87.91万
-
财政年份:2019
-
负责人:Roy S Herbst
-
依托单位:
Yale Cancer Center NCTN LAPS
-
批准号:10734497
-
项目类别:
-
资助金额:$12.0万
-
财政年份:2019
-
负责人:Roy S Herbst
-
依托单位:
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
-
批准号:10203850
-
项目类别:
-
资助金额:$200.37万
-
财政年份:2015
-
负责人:Roy S Herbst
-
依托单位:
Yale SPORE in Lung Cancer Developmental Research Program
-
批准号:10203857
-
项目类别:
-
资助金额:$8.96万
-
财政年份:2015
-
负责人:Roy S Herbst
-
依托单位:
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
-
批准号:9767058
-
项目类别:
-
资助金额:$213.48万
-
财政年份:2015
-
负责人:Roy S Herbst
-
依托单位:
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
-
批准号:9338869
-
项目类别:
-
资助金额:$71.51万
-
财政年份:2015
-
负责人:Roy S Herbst
-
依托单位:
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
-
批准号:8931829
-
项目类别:
-
资助金额:$218.5万
-
财政年份:2015
-
负责人:Roy S Herbst
-
依托单位:
MicroRNA-based interventions to prevent progression from lung preneoplasia to adenocarcinoma
-
批准号:9379210
-
项目类别:
-
资助金额:$20.76万
-
财政年份:2015
-
负责人:Roy S Herbst
-
依托单位:
Administrative Core
-
批准号:8931832
-
项目类别:
-
资助金额:$86.07万
-
财政年份:2015
-
负责人:Roy S Herbst
-
依托单位:
Personalizing NSCLC Therapy: Exploiting KRAS activated pathways
-
批准号:8920514
-
项目类别:
-
资助金额:$55.45万
-
财政年份:2011
-
负责人:Roy S Herbst
-
依托单位:
Personalizing NSCLC Therapy: Exploiting KRAS activated pathways
-
批准号:8707401
-
项目类别:
-
资助金额:$54.12万
-
财政年份:2011
-
负责人:Roy S Herbst
-
依托单位:
Personalizing NSCLC Therapy: Exploiting KRAS activated pathways
-
批准号:8517039
-
项目类别:
-
资助金额:$52.79万
-
财政年份:2011
-
负责人:Roy S Herbst
-
依托单位:
Personalizing NSCLC Therapy: Exploiting KRAS activated pathways
-
批准号:8332772
-
项目类别:
-
资助金额:$56.49万
-
财政年份:2011
-
负责人:Roy S Herbst
-
依托单位:
Personalizing NSCLC Therapy: Exploiting KRAS activated pathways
-
批准号:8186504
-
项目类别:
-
资助金额:$58.43万
-
财政年份:2011
-
负责人:Roy S Herbst
-
依托单位:
U10 Ful Member Application Affiliated with SWOG
-
批准号:7555078
-
项目类别:
-
资助金额:$21.59万
-
财政年份:2004
-
负责人:Roy S Herbst
-
依托单位:
U10 Full Member Application Affiliated with SWOG
-
批准号:7767468
-
项目类别:
-
资助金额:$32.57万
-
财政年份:2004
-
负责人:Roy S Herbst
-
依托单位:
Phase I trial of antiangiogenic agent SU6668 in Pt w solid tumors
-
批准号:6563965
-
项目类别:
-
资助金额:$29.68万
-
财政年份:2002
-
负责人:Roy S Herbst
-
依托单位:
Core--Clinical trials
-
批准号:6563968
-
项目类别:
-
资助金额:$29.68万
-
财政年份:2002
-
负责人:Roy S Herbst
-
依托单位:
Core--Clinical trials
-
批准号:6499818
-
项目类别:
-
资助金额:$29.68万
-
财政年份:2001
-
负责人:Roy S Herbst
-
依托单位:
海外基金